Pacific Life Re completes first two Japanese asset-intensive flow reinsurance deals
Life and health reinsurer Pacific Life Re has completed the first of two asset-intensive flow reinsurance transactions in Japan, marking its entry in the segment. The transactions were executed with two Japanese life insurers, representing a key milestone in Pacific…
Arch Capital’s Q3’25 underwriting income rises to $871m amid improved reinsurance result
Arch Capital Group Ltd., the Bermuda-based insurer and reinsurer, has reported a 62% year-on-year rise in underwriting income to $871 million for the third quarter of 2025, driven by a significantly stronger underwriting performance in its reinsurance business. Group-wide, Arch’s…
Everest enters $1.2bn adverse development reinsurance deal with Longtail Re
Bermuda-based insurance and reinsurance firm Everest has entered into an adverse development reinsurance agreement, effective October 1, 2025, supported by Longtail Re, an affiliate of Stone Ridge Holdings Group, with the cover composed of two layers in excess of the…
Flexible working and work-life balance: how to support your people
Flexible working is a key driver of wellbeing and engagement. Understand how different generations value flexible working and work-life balance in unique ways.
Cancellation rights don’t apply to tax-free cash withdrawals
HMRC and FCA confirm: cancellation rights don’t apply to PCLS/UFPLS. Once withdrawn, tax effects and allowances used are irreversible.
Long-term stochastic credit modelling for Matching Adjustment portfolios
A practical briefing which quantifies how often MA portfolios earn the Matching Adjustment across ratings, terms and strategies.
Stochastic credit modelling for Matching Adjustment portfolios
A practical briefing which quantifies how often MA portfolios earn the Matching Adjustment across ratings, terms and strategies.
BW cements growth ambitions in Scotland with move to Cadworks
We have officially relocated our Glasgow office, further strengthening our strategic growth ambitions in Scotland.
Perspectives from Employers on the Costs and Issues Associated with Covering GLP-1 Agonists for Weight Loss
While more large employers are covering GLP-1 drugs for weight loss, KFF’s conversations with employers highlight concerns about the cost of these medications. Many of these employers have considered scaling back coverage of GLP-1 agonists for weight loss, or in…
The Semi-Sad Prospects for Controlling Employer Health Care Costs
In a commentary on KFF’s 27th employer health benefits survey, President and CEO Dr. Drew Altman discusses the obstacles employers face trying to control their health care costs, and the reasons why they’ve never been meaningful supporters of government cost-containment…